of Dermatology. Immature DCs were generated from her monocytes. One week later she was hospitalized due to a lung infection with Mycobacterium avium complex. Monocyte-derived DCs during Mycobacterium avium infection expressed low levels of CDla and CD80 as determined by flow cytometry. They also expressed high levels of CD83 and CD86, and when stimulated with LPS for 24 hrs they slightly up-regulated CD83 and did not produce IL12. When monocyte-derived DCs were obtained from the patient after having recovered from the Mycobacterium avium complex infection, they expressed normal levels of CDla and CD80 and were negative both for CD83 and for CD86. IL12 production in response to LPS was restored. Inhibition of DC maturation by the in vivo infection with Mycobacterium avium may be an immune-evasion mechanism used by the pathogen because incompletely matured DCs may not activate effector T cells efficiently in vivo.
Mycobacteria other than Mycobacterium tuberculosis complex and Mycobacterium leprae have been associated with human diseases since the 1930s (l). However, with the advent of the AIDS epidemic and the introduction of immunosuppressive therapies, the incidence of these diseases has risen dramatically (2) . Among these mycobacteria, Mycobacterium avium complex is the most frequent pathogen that can cause pulmonary disease: this environmental microrganism, typically non-pathogenic and readily cleared via host defence pathways, it can invade and replicate in immunocompromised hosts with impunity. Mycobacterium avium complex causes pulmonary infections in HIV-infected patients and in immunocompromised individuals who have undergone organ transplants or those with inheritable defects in IFN-y, even if pulmonary infections in immunocompetent subjects have been described (3) (4) .
Dendritic cells (DCs), the most potent antigenpresenting cells, playa central role in the induction and regulation of protective immunity against microrganisms (5) (6) . In the lungs, immature DCs line alveolar spaces and readily take up foreign material (7) , including inhaled Mycobacteria. To present antigen efficiently, these immature DCs must differentiate into activated mature DC. During this process, the DCs phagocytic ability is down-regulated and the antigen-presenting capacity is up-regulated. Mature DCs express high levels of the antigenpresenting molecules' major-histocompatibility complex (MHC) class I, MHC class II and CDI and of T cell co-stimulatory molecules such as CD40, CD80 and CD86 on their surfaces (6) . These cells can migrate to regional lymph nodes by means of up-regulated surface expression of the chemokine receptor CCR7. Within lymph nodes, mature DCs interact with the abundant T cells that traffic through this site to activate both naive and memory T cell immunity.
It has been show that Mycobacterium tuberculosis is able to infect DCs generated in vitro (8) , and this infection inhibits phenotypic and functional DCs maturation (9) . Similar results have been found using Bacillus Calmette-Guerin which interferes with monocyte differentiation into DCs and impairs T-cell priming by these subverted DCs (10) . Mycobacterium avium complex is able to infect both macrophages and DCs but it does not impair infected monocytes differentiation (9) .
We describe a chronic graft-versus-host-disease (cGVHD) patient who developed a lung infection with Mycobacterium avium complex: during the infection the patient's monocytes failed to differentiate properly in immature DCs but when the infection was cleared monocyte differentiation in immature DCs was restored.
MATERIALS AND METHODS
In December 2004 a 54-year old woman affected by cGVHD was referred to our Division of Dermatology in order to start treatment with extracorporeal photochemotherapy. In June 2002 she had developed an acute myeloid leukaemia and had undergone a bone marrow transplant in January 2003. She developed a mild acute GVHD which was treated with corticosteroids and in November 2004 she developed cGVHD with severe skin involvement and moderate liver involvement. The day before starting extracorporeal photochemotherapy, immature DCs were generated from her monocytes. One week later she had a fever and a cough and she was hospitalized due to a lung infection with Mycobacterium avium complex: diagnosis was made through bronchial wash culture. In April 2005, after recovering from the infection which had been treated with azythromicin, ryfabutin and ethambutol, she was referred again to our Division of Dermatology to undergo extracorporeal photochemotherapy. cGVHD showed the same degree and was still characterized by severe skin involvement and moderate liver involvement(score 3 and 2 respectively). The day before starting this treatment immature DCs were generated again from her monocytes.
Generation ofimmature DCs in vitro
Peripheral blood mononuclear cells (PBMC) were isolated from the patient's and from control's sodium heparinized blood by density-gradient centrifugation over Ficoll-Hypaque (Pharmacia, Uppsala, Sweden) and washed twice in PBS. Monocytes were isolated from PBMC by positive selection with anti-CDI4-conjugated microbeads (Miltenyi Biotech Gmbh, Bergish Gladbach, Germany) according to the manufacturer's instructions. CDI4+ cells were 94%. Immature DCs were generated by the culturing of monocytes in RPMI 1640 medium supplemented with fetal calf serum (10%), L-glutamine (2 mM) penicillin-streptomycin (100 U/ml, 100 ug/ml), sodium pyruvate, nor 1 -essential aminoacids, recombinant IL4 (R&D Systems, Minneapolis, Minnesota) and GM-CSF (R&D Systems at a concentration of 5x I0 5 cells/ml for 6 days in Sarstetct 6-well plates at 37°C in 5% CO 2 , At day 3 cytokines were replenished.
DC phenotyping i
The following monoclonal antibodies were used (moAb): anti-CDla, ,-CDl4, -CD40, -CD80, -CD83, -CD86 and appropriate isotype controls (all purchased from Pharmingen). Cells were harvested and washed in PBS containing 1% FCE; and 0.1% NaN 3 (staining buffer) and stained using the' above-mentioned antibodies or appropriate isotype controls for background determination. Stained cells were analyzed by flow cytometry (PAS, Partee, Germany). Fluorescence intensity was calculated by computerized analysis of dot plots or histograms generated by at least 10000 viable cells.
Cytokine production
Patient's and control's immature DCs at day 6 of culture were washed, adjusted at 5x10 5 cells/ml and were cultured in the presence of I ug/ml for an additional 24 h to induce DC maturation. Supernatants were examined for ILl2 and ILiO by ELISA microtiter plates (Corning Easy Wash, Celbio, Milan, Italy) coated overnight with 2 ug/ml anti-IL-12 (anti-p70, Pharmingen) or anti-IL I0 capture mAb (Pharmingen) in 0.1 M N3:!HP04 pH 9 buffer and blocked with PBSffween. A biotin-labeled anti-IL-12 or anti-ILl 0 detecting antibody (Pharmingen) at I ug/ml in PBS/IO % fetal calf serum was used. The plates were developed using avidin-HRP (Vector, Burlingame, CA, USA) and 2,2 azino-bis substrate (Sigma). The lower limit of detection was 15.6 pg/ml.
RESULTS
The phenotype of monocyte-derived immature DCs in our patient differs from normal subjects.
After 6 days of culture in complete medium, immature DCs of our patient who had a lung infection sustained by Mycobacterium avium complex, expressed lower levels of CD Ia than immature DCs obtained from normal subjects (Fig. I) . They expressed normal levels of CD40, while CD80 expression was lower than normal subjects ( Fig. 2a) ; moreover, the patient's immature DCs expressed high levels of CD83 and CD86 that are usually absent or slightly expressed on immature DCs from normal subject's ( Fig. 2b) . When immature DCs from the patient were stimulated with LPS for 24 hrs, they slightly up-regulated CD83 (Fig .  3) . When the patient was studied again four months later, after having recovered from the Mycobacterium avium complex infection, immature DCs cultured in the same conditions expressed normal levels of CD Ia and CD80 and were negative both for CD83 and for CD86 ( Fig. 4) .
IL12 production of monocyte-derived immature Des in our patient differed from normal subjects. When immature Des of the patient with lung infection sustained by Mycobacterium avium complex were stimulated with LPS for 24 hrs in order to mature, they did not produce ILl2 (not detectable, normal controls = 4O±1O pg/ml), When the infection had been cleared, IL12 production by mature DCs was restored (35 pg/ml), DISCUSSION We describe monocyte-derived DC maturation in a cGVHD patient who developed Mycobacterium avium complex infection of the lungs. Before developing this infection the patient had been included in a study on DC function during extracorporeal photochemotherapy. The day before starting extracorporeal photochemotherapy, monocytes were obtained from the patient's peripheral blood and put in culture with IL4 and GM-CSF: after 6 days the immature monocyte-derived DCs showed an impairment of CD 1a and CD80 expression together with an upregulation of CD83 and CD86 and an impaired production of ILl2. At that time the patient had a fever and a cough and she was hospitalized due to a lung infection sustained by Mycobacterium avium complex. After having recovered from the lung infection thanks to the appropriate treatment, her monocytederived dendritic cell maturation and IL12 production were restored. This underlines the role of the infection in the impairment ofDCs maturation because in several cGVHD patients studied in our lab, monocyte-derived DCs differentiation is similar to normal subjects in spite oftreatment (data not shown).
Fig. 2. Flow cytometric analysis ofsurface phenotype ofimmature monocyte-derived DCs in our patient and in a control subject. Cell surface expression ofthe indicated molecules was determined by direct immunofluorescence. A: Histograms represent CD40 and CD80 expression and numbers indicate both the percentage of positive cells and the mean fluorescence intensity ofstained cells. An isotype-matched antibody was used as negative control (grey histograms). B: Histograms represent CD86 and CD83 expression and numbers indicate both the percentage ofpositive cells and the mean fluorescence intensity ofstained cells. An isotype-matched antibody was used as negative control (grey histograms).
Several microrganisms, such as viruses and the parasite Trypanosoma cruzi, can interfere with DC differentiation from monocyte precursors generating semi-professional APC characterized by a less stimulatory mode (11) (12) (13) . Both Mycobacterium tuberculosis and BCG interfere with monocyte differentiation: in particular BCG induces CDI-DCs with a peculiar mature phenotype, characterized by expression of CD83, CD86, CCR7 and class I molecule, despite a low up-regulation of CD80, CD40 and MHC class II molecules (10) . These cells are also unresponsive to LPS, demonstrating that the level of DC maturation is low and unrecoverable.
Interestingly, the phenotype and function of DCs derived from Mycobacterium avium-infected monocytes are indistinguishable from that of controls (10) . This may be due to differences in structural components of the cell wall: LAM of Mycobacterium avium do not bind to DC-SIGN, a member of the B-integrin family that is involved in internalization of mycobacteria by DC (14) (15) .
Our in vivo data are in contradiction with the in vitro data because immature DCs of our patient are very similar to those obtained in vitro after BCG infection. It is important to underline that our in vivo model is different from the in vitro one in which monocytes are infected with Mycobacterium avium complex: in our patient it is unlikely that circulating monocytes were infected with the bacteria because the infection was confined to the lungs. However, the hypothesis that the Mycobacterium avium infection itself impaired DC function was confirmed by the fact that the normal monocyte-derived DC phenotype was restored in the same patient when the Mycobacterium avium infection was over.
Inhibition of DC maturation induced by Mycobacterium avium infection may be an immuneevasion mechanism that is used by the pathogen to evade host immune responses: CD 1 molecules present glycolipids of the mycobacterial wall to T cells that secrete IFN-y and are capable ofkilling infected target cells (16) . The failure ofCD 1a expression on immature DCs in our patient could reduce the presentation of non-peptide microbial antigens to CD I-restricted T cells, reducing the so-called "signal 1". Moreover, the reduced up-regulation of a co-stimulatory molecule such as CD80 in our patient's immature DCs could be responsible for an impaired "signal 2" that is required for an efficient T-cell priming. Finally, our patient's DCs failed to secrete ILl2 after LPS treatment. ILl2 is considered a key cytokine in T-cell priming and Thl polarization, thus a defect in its secretion may account for a less stimulatory mode and inability to induce a marked Thl polarization. In a family with an apparent genetic susceptibility to disseminated Mycobacterium avium complex infection, an underlying defect in IL 12 regulation leading to an abnormal IFN-y production has been described (17) .
In conclusion, the inhibition ofDC maturation by the in vivo infection with Mycobacterium avium may be an immune-evasion mechanism that is used by the pathogen to evade host immune responses because incompletely matured DCs are unable to activate effector T cells efficiently in vivo or because they are tolerogenic.
